LSV Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.37M | Hold |
169,900
| – | – | ﹤0.01% | 588 |
|
|
2025
Q1 | $1.42M | Buy |
+169,900
| New | +$1.42M | ﹤0.01% | 595 |
|
|
2024
Q3 | – | Sell |
-1,057,300
| Closed | -$6.71M | – | 824 |
|
|
2024
Q2 | $6.71M | Sell |
1,057,300
-8,300
| -0.8% | -$52.7K | 0.01% | 482 |
|
|
2024
Q1 | $6.46M | Sell |
1,065,600
-23,700
| -2% | -$144K | 0.01% | 495 |
|
|
2023
Q4 | $6.61M | Sell |
1,089,300
-340,000
| -24% | -$2.06M | 0.01% | 492 |
|
|
2023
Q3 | $6.03M | Buy |
1,429,300
+136,100
| +11% | +$574K | 0.01% | 497 |
|
|
2023
Q2 | $4.01M | Sell |
1,293,200
-104,000
| -7% | -$322K | 0.01% | 543 |
|
|
2023
Q1 | $1.94M | Hold |
1,397,200
| – | – | ﹤0.01% | 609 |
|
|
2022
Q4 | $2.78M | Hold |
1,397,200
| – | – | 0.01% | 563 |
|
|
2022
Q3 | $2.82M | Sell |
1,397,200
-135,000
| -9% | -$273K | 0.01% | 561 |
|
|
2022
Q2 | $4.87M | Sell |
1,532,200
-20,000
| -1% | -$63.6K | 0.01% | 513 |
|
|
2022
Q1 | $6.47M | Sell |
1,552,200
-19,000
| -1% | -$79.2K | 0.01% | 494 |
|
|
2021
Q4 | $7.53M | Buy |
1,571,200
+25,600
| +2% | +$123K | 0.01% | 490 |
|
|
2021
Q3 | $8.25M | Hold |
1,545,600
| – | – | 0.01% | 476 |
|
|
2021
Q2 | $7.91M | Buy |
1,545,600
+282,000
| +22% | +$1.44M | 0.01% | 491 |
|
|
2021
Q1 | $8.5M | Buy |
1,263,600
+171,800
| +16% | +$1.16M | 0.01% | 491 |
|
|
2020
Q4 | $4.99M | Sell |
1,091,800
-21,500
| -2% | -$98.2K | 0.01% | 557 |
|
|
2020
Q3 | $4.32M | Buy |
1,113,300
+177,500
| +19% | +$689K | 0.01% | 555 |
|
|
2020
Q2 | $4.45M | Buy |
935,800
+580,000
| +163% | +$2.76M | 0.01% | 558 |
|
|
2020
Q1 | $1.24M | Sell |
355,800
-11,800
| -3% | -$41.1K | ﹤0.01% | 700 |
|
|
2019
Q4 | $1.77M | Hold |
367,600
| – | – | ﹤0.01% | 690 |
|
|
2019
Q3 | $1.07M | Buy |
+367,600
| New | +$1.07M | ﹤0.01% | 739 |
|